Cargando…

Dupuytren’s interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial

BACKGROUND: Dupuytren’s contracture is a fibro-proliferative disease of the hands affecting over 2 million UK adults, particularly the white, male population. Surgery is the traditional treatment; however, recent studies have indicated that an alternative to surgery—collagenase clostridium histolyti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dias, Joseph, Arundel, Catherine, Tharmanathan, Puvan, Keding, Ada, Welch, Charlie, Corbacho, Belen, Armaou, Maria, Leighton, Paul, Bainbridge, Christopher, Craigen, Michael, Flett, Lydia, Gascoyne, Samantha, Hewitt, Catherine, James, Elaine, James, Sophie, Johnson, Nick, Jones, Judy, Knowlson, Catherine, Radia, Priya, Torgerson, David, Warwick, David, Watson, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481756/ https://www.ncbi.nlm.nih.gov/pubmed/34593024 http://dx.doi.org/10.1186/s13063-021-05595-w

Ejemplares similares

Can learnings from the COVID-19 pandemic improve trial conduct post-pandemic? A case study of strategies used by the DISC trial
por: Knowlson, Catherine, et al.
Publicado: (2022)

Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial
por: Ronaldson, Sarah J, et al.
Publicado: (2021)

Reverse shoulder arthroplasty versus hemiarthroplasty versus non-surgical treatment for older adults with acute 3- or 4-part fractures of the proximal humerus: study protocol for a randomised controlled trial (PROFHER-2: PROximal Fracture of Humerus Evaluation by Randomisation – Trial Number 2)
por: Rangan, Amar, et al.
Publicado: (2023)

Examination of early treatment effects and related biases during the conduct of two UK-wide pragmatic orthopaedic surgical trials: ProFHER and UK FROST
por: Knowlson, Catherine N., et al.
Publicado: (2023)

The impact of surgeon and patient treatment preferences in an orthopaedic trauma surgery trial
por: Keding, Ada, et al.
Publicado: (2019)

Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial
por: Knowlson, Catherine, et al.
Publicado: (2020)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Cost-effectiveness of surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: an economic evaluation of the UK FROST trial
por: Corbacho, Belen, et al.
Publicado: (2021)

Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial
por: Aglen, Terese, et al.
Publicado: (2019)

Bah humbug! Association between sending Christmas cards to trial participants and trial retention: randomised study within a trial conducted simultaneously across eight host trials
por: Coleman, Elizabeth, et al.
Publicado: (2021)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Delayed vascular complication after collagenase injection for Dupuytren disease
por: Nordenskjöld, Jesper, et al.
Publicado: (2023)

Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture
por: Bainbridge, Chris, et al.
Publicado: (2012)

Recruiting ahead of target: What worked in the REEACT trial?
por: Tharmanathan, Puvan, et al.
Publicado: (2011)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren’s Contracture
por: Sahemey, Rajpreet S, et al.
Publicado: (2021)

Botulinum toxin as an adjunct for severe Dupuytren’s contracture treated with collagenase injections
por: Denkler, Keith A., et al.
Publicado: (2022)

A nested randomised controlled trial of a leaflet, containing information on research, to increase the recruitment rate of reform (reducing falls with orthoses and a multifaceted podiatry) trial participants
por: Arundel, Catherine, et al.
Publicado: (2013)

The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
por: Tharmanathan, Puvan, et al.
Publicado: (2008)

Collagenase Management of Multicord Dupuytren’s Disease under Intravenous Sedation: A Prospective Cohort Study
por: Wiseman, Jeremy, et al.
Publicado: (2019)

Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial
por: Nordenskjöld, Jesper, et al.
Publicado: (2019)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
por: Abdelrahman, Islam, et al.
Publicado: (2020)

Ongoing validation of health-related quality of life instruments
por: Cocks, Kim, et al.
Publicado: (2015)

Postapproval clinical experience in the treatment of Dupuytren’s contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days
por: Schulze, Scott M., et al.
Publicado: (2014)

No difference found in time to publication by statistical significance of trial results: a methodological review
por: Jefferson, L, et al.
Publicado: (2016)

Comparative Effectiveness of Needle Aponeurotomy and Collagenase Injection for Dupuytren’s Contracture: A Multicenter Study
por: Zhou, Chao, et al.
Publicado: (2017)

Vascular Complication after Collagenase Injection and Manipulation for Dupuytren’s Contracture: A Case Report
por: Kawano, Yusuke, et al.
Publicado: (2019)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022)

111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
por: Steppe, Cyrus S., et al.
Publicado: (2023)

Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up
por: Strömberg, Joakim, et al.
Publicado: (2018)

Collagenase clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
por: Warwick, D., et al.
Publicado: (2015)

Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study
por: Atroshi, Isam, et al.
Publicado: (2014)

Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol
por: Malafa, Menyoli M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tdhgc2mq895rp4ikd0eblf4hbt